Erik Wambre
7PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Dec 14, 2024
Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II Study.Sayantani B Sindher, Kari C Nadeau, R Sharon Chinthrajah
|Dec 14, 2024
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy.R Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau
|Dec 19, 2023
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy.Astrid L Voskamp, Sugandhika Khosa, Tracy Phan
|Nov 27, 2023
Safety and immunopharmacology of ASP0892 in adults or adolescents with peanut allergy: two randomized trials.Brian C Ferslew, Ronald Smulders, Tong Zhu
|Mar 10, 2022
Oral desensitization therapy for peanut allergy induces dynamic changes in peanut-specific immune responses.Veronique Bajzik, Hannah A DeBerg, Nahir Garabatos
|Oct 02, 2021
Clinical and immunological evaluation of cat-allergic asthmatics living with or without a cat.Erik R Wambre, Mary Farrington, Veronique Bajzik
Pageof 2
Frequent Collaborators
3 joint publications
Hannah A DeBerg
3 joint publications
Kari C Nadeau
2 joint publications
Jennifer D Hamilton
2 joint publications
Jamie M Orengo
2 joint publications
R Sharon Chinthrajah
1 joint publications
Jonathan H DeLong
1 joint publications
Kimberly O'Brien
1 joint publications
Sayantani B Sindher
1 joint publications
Cate Speake
1 joint publications
Elizabeth Whalen
